| Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology AMA van der Wiel, L Schuitmaker, Y Cong, J Theys, A Van Hoeck, C Vens, ... Cancers 14 (17), 4157, 2022 | 13 | 2022 |
| Overcoming radioresistance with the hypoxia-activated prodrug CP-506: A pre-clinical study of local tumour control probability A Yaromina, L Koi, L Schuitmaker, LJ Dubois, M Krause, P Lambin Radiotherapy and Oncology 186, 109738, 2023 | 3 | 2023 |
| Homologous recombination deficiency: mutations and beyond–implications for precision oncology AMA van der Wiel, L Schuitmaker, Y Cong, J Theys, A van Hoeck, C Vens, ... Overcoming tumor hypoxia, 125, 0 | | |
| A deficiency in the homologous recombination or the Fanconi anemia pathway enhances the antitumor effects of the hypoxia-activated prodrug CP-506 AMA van der Wiel, A Yaromina, L Schuitmaker, D Marcus, NG Lieuwes, ... Overcoming tumor hypoxia, 99, 0 | | |
